SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,764.23 -813.35
( -1.08%)

Global Indices

Nasdaq

52,820.00 -615.25
(-1.15%)

Dow Jones

7,695.68 -43.92
(-0.57%)

Hang Seng

65,089.68 -179.65
(-0.28%)

Nikkei 225

10,664.98 -146.68
(-1.36%)

Forex

USD-INR

94.51 0.08
(0.08%)

EUR-INR

109.83 0.16
(0.15%)

GBP-INR

127.88 0.26
(0.20%)

JPY-INR

0.61 0.01
(0.93%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.59

14796.27

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.6

Back

Amerise Biosciences reports standalone net loss of Rs 0.08 crore in the June 2026 quarter

Aug 04,2026

Net Loss of Amerise Biosciences reported to Rs 0.08 crore in the quarter ended June 2026 as against net loss of Rs 0.01 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.

74,764.23 -813.35 ( -1.08%)

52,820.00 -615.25 (-1.15%)

7,695.68 -43.92 (-0.57%)

65,089.68 -179.65 (-0.28%)

10,664.98 -146.68 (-1.36%)

94.51 0.08 (0.08%)

109.83 0.16 (0.15%)

127.88 0.26 (0.20%)

0.61 0.01 (0.93%)